The latest drug and pharmaceutical development news New York Medical and Pharma Insider

Cannabinoid Drug

Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology

DehydraTECH evidenced an ability to deliver some drugs more effectively across the blood brain barrier.

HempMy Pet and Tarleton University announce positive results of their study using CBD on horses

HempMy Pet, a division of HM Health, LLC, offers CBD-infused products for dogs, cats, and horses.

Mindset Pharma develops an intranasal platform for psychedelic medicines

Mindset Pharma is focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological disorders.

A2W Pharma and MedC Biopharma Partner to develop Cannabinoid Therapeutics

A2W is a subsidiary of Amino Chemicals of Malta, which is a subsidiary of ABA Chemicals of China, a global pharmaceutical company.

InMed seeks patents for cannabinoid analogs

The patent application covers new chemical entities that can be compared to other drugs in order to select candidates for advancement.

Trait Biosciences advances water-soluble cannabinoid technology to prepare for 2022 product launch

Trait Biosciences is a leader in cannabinoid research, focused on developing technologies that enable the production of safe CBD produccts.

Vancouver-based Trait Biosciences advances its technology for the CBD infused product market

Trait is developing cannabinoid technologies delivering water-soluble extracts to formulate higher quality CBD infused products.

MD Farma closes funding and changes name to Corganics to expand cannabinoid product lines

Corganics' clinical cannabinoid therapy portfolio is available exclusively through healthcare professionals.

Medicortex FInland Oy seeks investment to develop a rapid diagnostic test to detect concussions

The investments will also pave the way towards an IPO – Medicortex has reached a point of maturity developing the prototype, and is ready...